| Dr Donald Joseph Rivard, MD | |
|
25 Hackett Blvd, Division Of Urology (mc 208), Albany, NY 12208-3420 | |
| (518) 262-3341 | |
| (518) 262-6660 |
| Full Name | Dr Donald Joseph Rivard |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 25 Hackett Blvd, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912967241 | NPI | - | NPPES |
| 00371435 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 121265 (New York) | Primary |
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
The drought in the Horn of Africa "emphasizes the gap between our rapidly increasing ability to predict disasters, thanks largely to advances in science and technology, and our capacity to generate the political will to carry out effective mitigation strategies," according to a SciDev.Net opinion piece by editor David Dickson.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
Today's headlines include reports about the latest developments for those states that are running their own health insurance exchanges and facing difficulties.
A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.
› Verified 7 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
The drought in the Horn of Africa "emphasizes the gap between our rapidly increasing ability to predict disasters, thanks largely to advances in science and technology, and our capacity to generate the political will to carry out effective mitigation strategies," according to a SciDev.Net opinion piece by editor David Dickson.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
Today's headlines include reports about the latest developments for those states that are running their own health insurance exchanges and facing difficulties.
A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald Joseph Rivard, MD 711 Troy Schenectady Rd, Suite 201, Latham, NY 12110-2442 Ph: (518) 782-3700 | Dr Donald Joseph Rivard, MD 25 Hackett Blvd, Division Of Urology (mc 208), Albany, NY 12208-3420 Ph: (518) 262-3341 |
News Archive
The drought in the Horn of Africa "emphasizes the gap between our rapidly increasing ability to predict disasters, thanks largely to advances in science and technology, and our capacity to generate the political will to carry out effective mitigation strategies," according to a SciDev.Net opinion piece by editor David Dickson.
Onconova Therapeutics®, Inc. announced agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase 3 trial for Estybon™ (ON 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), diseases affecting the production of healthy blood cells in the bone marrow.
Today's headlines include reports about the latest developments for those states that are running their own health insurance exchanges and facing difficulties.
A mosquito sample collected three decades ago in Israel's Negev Desert has yielded an unexpected discovery: a previously unknown virus that's closely related to some of the world's most dangerous mosquito-borne pathogens but, curiously, incapable of infecting non-insect hosts.
› Verified 7 days ago
Dr. Jonah Marshall, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd Ste 106, Albany, NY 12208 Phone: 518-438-1019 Fax: 518-489-7642 | |
Rebecca Leigh O'malley, MD Urology Medicare: Medicare Enrolled Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Brian Patrick Murray, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4 Executive Park, Albany, NY 12203 Phone: 518-489-7494 Fax: 518-489-7641 | |
Dr. Adam Shattuck Howe, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd # Mc-108, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Dr. Robert Charles Welliver Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 23 Hackett Blvd, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Jean G. Hollowell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 23 Hackett Blvd, Mc 208, Albany, NY 12208 Phone: 518-262-3341 Fax: 518-262-6660 | |
Barry Kogan, Urology Medicare: Medicare Enrolled Practice Location: South Clinical Campus, 23 Hackett Blvd. (mc 208), Albany, NY 12208 Phone: 518-262-3341 |